Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease - Wikidata - awgldk - TriplyDB

Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease

Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease

http://www.wikidata.org/entity/Q28317131

about

Functional characterization and mechanism of action of recombinant human kynurenine 3-hydroxylase Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types Acute tryptophan depletion in humans: a review of theoretical, practical and ethical aspects The physiological action of picolinic Acid in the human brain Quinolinic acid selectively induces apoptosis of human astrocytes: potential role in AIDS dementia complex.Current Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple Sclerosis Kynurenine 3-Monooxygenase: An Influential Mediator of Neuropathology The role of inflammation in suicidal behaviour Immunomodulatory properties of cacao extracts - potential consequences for medical applications Kynurenines in the mammalian brain: when physiology meets pathology Structure, expression, and function of kynurenine aminotransferases in human and rodent brains Changing the face of kynurenines and neurotoxicity: therapeutic considerations Elevated cerebrospinal fluid kynurenic acid levels in patients with tick-borne encephalitis Labelled alpha-methyl-L-tryptophan as a tracer for the study of the brain serotonergic system Human microglia convert l-tryptophan into the neurotoxin quinolinic acid Tryptophan-2,3-dioxygenase (TDO) inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolites Behavioral disturbances in adult mice following neonatal virus infection or kynurenine treatment--role of brain kynurenic acid.Neonatal infection with neurotropic influenza A virus induces the kynurenine pathway in early life and disrupts sensorimotor gating in adult Tap1-/- mice.Neurotoxic and neuroprotective metabolites of kynurenine in patients with renal cell carcinoma treated with interferon-alpha: course and relationship with psychiatric status.The excitotoxin quinolinic acid induces tau phosphorylation in human neurons Kynurenic Acid levels in cerebrospinal fluid from patients with Alzheimer's disease or dementia with lewy bodies.A link between central kynurenine metabolism and bone strength in rats with chronic kidney disease.Tryptophan Metabolism in Allergic Disorders CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways.Microglial Activation in the Pathogenesis of Huntington's Disease.Elevated levels of kynurenic acid in the cerebrospinal fluid of patients with bipolar disorder.Redox reactions related to indoleamine 2,3-dioxygenase and tryptophan metabolism along the kynurenine pathway.Differential effects of sertraline in a predator exposure animal model of post-traumatic stress disorder Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection.The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder.L-tryptophan-L-kynurenine pathway metabolism accelerated by Toxoplasma gondii infection is abolished in gamma interferon-gene-deficient mice: cross-regulation between inducible nitric oxide synthase and indoleamine-2,3-dioxygenase.Inflammation-associated depression: from serotonin to kynurenine Understanding cytokines. Part I: Physiology and mechanism of action.Tryptophan metabolites and brain disorders.Kynurenines: from the perspective of major psychiatric disorders.Fatigue in patients with lung cancer is related with accelerated tryptophan breakdown.The kynurenine pathway is involved in bacterial meningitis.Regulation of indoleamine 2,3-dioxygenase expression in simian immunodeficiency virus-infected monkey brains.Study of the brain serotonergic system with labeled alpha-methyl-L-tryptophan.

P2860

Q22253175-2940BAF2-2702-4D08-B12F-B59CD6C9E899 Q24310976-0A932247-EA17-4DBD-AD46-316137F23179 Q24629807-86F08897-AE76-4154-8108-F0DE8C687E22 Q24634995-632282F2-E142-4DF3-B9C4-D24011AA316A Q24814135-77E3A13C-F79A-48DC-BE96-39C1516D4F23 Q26740330-B3B823AA-50CE-4C7C-B2D7-E0120ECF53AB Q26782867-074BA6E3-0919-4816-98F3-03ECC23927A6 Q26800426-D0046E08-900C-40F6-A2E4-7632AEA3C2AE Q26853328-03B09E7A-5937-4EE6-9FA4-0BC13B89E027 Q27003296-795DCD2A-44DA-449E-BC1E-1672E4603482 Q27657768-B82CF169-920A-4C48-9D65-15589E8AB527 Q28085041-162CC2C8-D5F5-4C91-88DC-6286092BC0BD Q28262656-587C2FC4-68D6-48D0-8935-23432279C72B Q28361167-EE785EF4-63E0-4E85-9716-32655EA1BBED Q28379366-E596AD7F-A3C2-4AB1-9538-AE2B87D676CC Q28834131-6EBAC52B-FA42-42FD-9B51-4AB3B17AD75C Q30419650-14EF241D-75D8-4CAA-81FE-F42A8E85F974 Q30475641-7BE7F287-A3F0-4A41-82CF-37082A6E4AB0 Q33379228-DF3DF2AB-9EBA-4C4B-B0F6-F25C91F5E851 Q33485236-FEF49203-87A8-4026-8B24-F47E12218215 Q33572850-B56741AB-844B-4C2D-A77B-721808411443 Q33592717-89DE7F76-342B-47FF-AD54-D5159563E756 Q33693287-BC961656-81E8-4528-A83D-6091A13E4E7D Q33751166-C8C30BB4-A4A1-4DA9-B4A2-B32C1BA18511 Q33779682-4813CD7A-DC79-4C96-9E15-5AFABCD3322C Q33809556-FDD1C948-50E4-42F1-9C79-B89E7969240B Q33816563-EC62ABE3-CAEF-41E0-9680-10CEAB97D19D Q33871711-E8604ACA-3E18-4DDA-AD0A-F1C27DED2085 Q33972544-3FCF3E80-4AE5-4C87-AF78-1EA4585B1FEF Q33975360-29B8E09B-ED62-43BE-BCA6-BE61D1DB8F17 Q34088944-ABE0351D-7F3F-40FA-8CC4-CE7F6D83D6C6 Q34116625-7FFDF7BF-9513-4D1A-BF2B-428A3BDAABFC Q34147377-6EB097E3-2625-42F7-8891-5EA12C64D368 Q34171362-A36DDACB-987E-4936-BD46-FB28E5AFC818 Q34225314-F7CCEAEC-C399-4976-88B9-330B22B4D97A Q34260092-EEFB0B91-A77B-4747-A538-CA3E2D8910F8 Q34277561-36ACC7D4-3142-43B9-A946-AAE7FE647413 Q34306405-030AB231-FC0D-44C2-9D51-41A49F6EBD61 Q34359001-A66A7E37-BBDB-40A3-9FD9-D1C623C3A610 Q34386607-DF76A77A-0311-4CE9-BF69-6C9987E049BC

P2860

Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease

http://www.wikidata.org/entity/Q28317131

description

1992 nî lūn-bûn

@nan

1992 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1992 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

1992年の論文

@ja

1992年論文

@yue

1992年論文

@zh-hant

1992年論文

@zh-hk

1992年論文

@zh-mo

1992年論文

@zh-tw

1992年论文

@wuu

name

Quinolinic acid and kynurenine ...... lammatory neurological disease

@ast

Quinolinic acid and kynurenine ...... lammatory neurological disease

@en

Quinolinic acid and kynurenine ...... lammatory neurological disease

@nl

type

label

Quinolinic acid and kynurenine ...... lammatory neurological disease

@ast

Quinolinic acid and kynurenine ...... lammatory neurological disease

@en

Quinolinic acid and kynurenine ...... lammatory neurological disease

@nl

prefLabel

Quinolinic acid and kynurenine ...... lammatory neurological disease

@ast

Quinolinic acid and kynurenine ...... lammatory neurological disease

@en

Quinolinic acid and kynurenine ...... lammatory neurological disease

@nl

P1433

Q28317131-4B35FDAA-28D1-4B34-97AB-FBB25E9944CB

P1476

Q28317131-3302217A-E699-4BB0-9B88-B4B8F952A166

P2093

Q28317131-195CA3B9-FE72-4A02-A97B-B0F2B1A13EC1

Q28317131-2153C7A5-D35A-452C-AFB0-27D19F79E1F8

Q28317131-32971A81-6CA4-4FF4-BA04-1732B9AB55A1

Q28317131-91E91001-1979-476E-BBFF-84A19BF7C29B

Q28317131-9B79DE09-61BB-4560-887F-497D953601CF

Q28317131-CA775918-EE4A-4B8B-88B0-07905F90AD0C

Q28317131-D2B2EDE4-46AB-4705-90DF-479108DEEF4C

Q28317131-D643A900-06C6-4DA1-A5E2-46490997A204

Q28317131-F41EAA95-8760-40B5-8704-DC3C3525E5EE

Q28317131-FE797CDE-4EAE-4952-ABE6-C05B72EE8972

P304

Q28317131-EFAD5C66-B086-401C-B7C5-588BF962577F

P31

Q28317131-0372A9E8-B8BB-493F-8672-A4F3CAA5EE92

P3181

Q28317131-BA6E6E63-7BDD-407F-B77C-19991D5EAD68

P356

Q28317131-B4B2DAD1-6F90-4D91-90E7-73532C7A0067

P407

Q28317131-B568FA19-48F8-4E21-B366-1BDAEAFE3E9F

P478

Q28317131-A4E81A21-120F-4B32-8F79-82EF16C40C0E

P577

Q28317131-A5AC8D4D-3B38-4E68-9837-32847AC73C99

P5875

Q28317131-85E707E2-F5BF-46B3-9A50-866F90EF1973

P698

Q28317131-ABB86340-3832-4B0C-8B4B-C1D1E45BFCC6

P921

Q28317131-D51BD2E9-9D99-4101-8875-1F73746F646B

P3181

P356

P1433

P1476

Quinolinic acid and kynurenine ...... lammatory neurological disease

@en

P2093

A Lackner

http://www.w3.org/2001/XMLSchema#string

J Elia

http://www.w3.org/2001/XMLSchema#string

J S Crowley

http://www.w3.org/2001/XMLSchema#string

K Saito

http://www.w3.org/2001/XMLSchema#string

L A Dilling

http://www.w3.org/2001/XMLSchema#string

L E Davis

http://www.w3.org/2001/XMLSchema#string

M A Demitrack

http://www.w3.org/2001/XMLSchema#string

M Der

http://www.w3.org/2001/XMLSchema#string

M J Kruesi

http://www.w3.org/2001/XMLSchema#string

M P Heyes

http://www.w3.org/2001/XMLSchema#string

P304

1249-73

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1582992

http://www.w3.org/2001/XMLSchema#string

P356

10.1093/BRAIN/115.5.1249

http://www.w3.org/2001/XMLSchema#string

P407

P478

115 ( Pt 5)

http://www.w3.org/2001/XMLSchema#string

P577

1992-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

31147568

http://www.w3.org/2001/XMLSchema#string

P698

1422788

http://www.w3.org/2001/XMLSchema#string

P921